$CTSO News
Last published 2d ago
- 2d agoCTSOCytoSorbents to Participate at the 2026 Jefferies Global Healthcare Conference in LondonPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...
- 1w agoCTSOCytoSorbents to Report Third Quarter 2026 Financial Results and Recent Business HighlightsPR NewswirePRINCETON, N.J., Oct. 29, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification,
- 1mo agoCTSOCytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical CarePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1mo agoCTSOCytoSorbents Regains Compliance with Nasdaq Minimum Bid Price RequirementPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 2mo agoCTSOCytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment ConferencePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 2mo agoCTSOCytoSorbents Announces Reverse Stock SplitPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 2mo agoCTSOCytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission MeetingsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 3mo agoCTSOCytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 3mo agoCTSOCytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 4mo agoCTSOCytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026GlobeNewswirePRINCETON, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood
- 6mo agoCTSOCytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 6mo agoCTSOCytoSorbents to Report First Quarter 2026 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 7mo agoCTSOCytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 7mo agoCTSOCytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026PR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 8mo agoCTSOCytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 10mo agoCTSOCytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 10mo agoCTSOTransforming Critical Care: CytoSorbents Blood-Purification Programs - CYTOSORBENTS CORPEarnings Call TranscriptsGood. Good morning, everyone. My name is Jason Colbert. I am the Senior Biotechnology Analyst, really the Senior Healthcare Analyst at D. Burrell Capital. One of the companies that I've been following for got to be 10, m
- 11mo agoCTSOCytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025PR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 11mo agoCTSOUpdated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in LondonPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 12mo agoCTSOCytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents to Participate at the Jefferies Global Healthcare Conference in LondonPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOIn Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical OfficerPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in CopenhagenPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Provides DrugSorb-ATR Regulatory UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis DayPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment ConferencePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATRPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytosorbents Corporation (CTSO) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoCTSOCytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Leads a New Era in Sepsis TreatmentPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATRPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and...
- 1y agoCTSOCytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATRPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents to Participate at the Jefferies Global Healthcare ConferencePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025PR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Reports First Quarter 2025 Financial Results and Provides Business UpdatePR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Provides Regulatory Update for DrugSorb-ATRPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and...
- 1y agoCTSOCytoSorbents to Report First Quarter 2025 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer ProgramPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate ControllerPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North AmericaPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Extends Expiration Date of Outstanding Series B Right WarrantsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual AuditPR NewswireCytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
- 1y agoCTSOCytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate ControllerGlobeNewswirePRINCETON, N.J., March 04, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood
- 1y agoCTSOCytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsGlobeNewswirePRINCETON, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood
- 1y agoCTSOCytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right WarrantsGlobeNewswirePRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood
- 1y agoCTSOCytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights OfferingGlobeNewswireOversubscribed Rights Offering Generated $6.25 Million in Aggregate Gross Proceeds Offering Proceeds Satisfies Debt Covenant, Unlocking $5.0 Million in Restricted Cash Currently on the Balance Sheet PRINCETON, N.J.,
- 1y agoCTSOCytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in DubaiGlobeNewswirePRINCETON, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood